# A Single-arm Study to Evaluate Safety and Effectiveness of VX-548 for Acute Pain

> **NCT05661734** · PHASE3 · COMPLETED · sponsor: **Vertex Pharmaceuticals Incorporated** · enrollment: 258 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Suzetrigine

## Key facts

- **NCT ID:** NCT05661734
- **Lead sponsor:** Vertex Pharmaceuticals Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-09
- **Primary completion:** 2023-12-12
- **Final completion:** 2023-12-12
- **Target enrollment:** 258 (ACTUAL)
- **Last updated:** 2025-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05661734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05661734, "A Single-arm Study to Evaluate Safety and Effectiveness of VX-548 for Acute Pain". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05661734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*